This is the authors' abstract. We don't add key points for this paper.
In this paper, we present the synthesis and SAR as well as selectivity, pharmacokinetic, and infection model data for representative analogues of a novel series of potent antibacterial LpxC inhibitors represented by hydroxamic acid.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Brown et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: